- ►diabetesjournals.org J Martin, ZQ Wang, XH Zhang, D Wachtel, J … - Diabetes Care, 2006 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Thirty-seven subjects with type 2 diabetes were
evaluated. After baseline, subjects were placed on a sulfonylurea (glipizide
gastrointestinal therapeutic system 5 mg/day) with placebo for 3 months. ... Cited by 50 - Related articles - BL Direct - All 9 versions
- ►diabetesjournals.org N Kleefstra, ST Houweling, FGA Jansman, KH … - Diabetes Care, 2006 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—In this 6-month double-blind study, patients with
an HbA 1c (A1C) >8% and insulin requirements of >50 units/day were randomly
assigned to receive treatment with placebo or 500 or 1,000 μg chromium ... Cited by 35 - Related articles - BL Direct - All 9 versions
CL Broadhurst, P Domenico - Diabetes Technology & Therapeutics, 2006 - liebertonline.com Chromium (Cr) picolinate (CrPic) is a widely used nutritional supplement for
optimal insulin function. A relationship among Cr status, diabetes, and
associated pathologies has been estab- lished. Virtually all trials using ... Cited by 27 - Related articles - BL Direct - All 3 versions
WT Cefalu, FB Hu - Diabetes Care, 2004 - Am Diabetes Assoc Despite widespread use by patients with diabetes and anecdotal reports in the
past regarding its efficacy, until recently, data in humans concerning
chromium's effects on insulin action in vivo or on cellular aspects of ... Cited by 83 - Related articles - All 5 versions
- ►nih.gov GR Pattar, L Tackett, P Liu, JS Elmendorf - Mut. Res.-Genetic Toxicology and Environmental …, 2006 - Elsevier Since trivalent chromium (Cr 3+ ) enhances glucose metabolism, interest in the
use of Cr 3+ as a therapy for type 2 diabetes has grown in the mainstream
medical community. Moreover, accumulating evidence suggests that Cr 3+ may ... Cited by 18 - Related articles - All 6 versions
- ►diabetesjournals.org [PDF] J Komorowski, V Juturu - Diabetes Care, 2005 - Am Diabetes Assoc Clinical indexes of insulin resistance (IR) have acquired increasing im-
portance with the development of various drugs that improve endogenous insulin
action (1). Recently, the largest database on insulin clamp studies has ... Cited by 28 - Related articles - BL Direct - All 10 versions
M Vrtovec, B Vrtovec, A Briski, A Kocijancic … - American Heart Journal, 2005 - Elsevier Although baseline QTc interval was similar in both groups (422 ± 34
milliseconds in group A vs 425 ± 24 milliseconds in group B, P = .77), QTc
interval at 3 months was shorter in group A (406 ± 35 milliseconds) than ... Cited by 13 - Related articles - All 23 versions
- ►endojournals.org G Chen, P Liu, GR Pattar, L Tackett, P … - Molecular Endocrinology, 2006 - Endocrine Soc Evidence suggests that chromium supplementation may alleviate symptoms
associated with diabetes, such as high blood glucose and lipid abnormalities,
yet a molecular mechanism remains unclear. Here, we report that trivalent ... Cited by 29 - Related articles - BL Direct - All 4 versions
H Wang, A Kruszewski, DL Brautigan - Biochemistry, 2005 - pubs.acs.org Chromium has been recognized for decades as a nutritional factor that improves
glucose tolerance by enhancing in vivo insulin action, but the molecular
mechanism is unknown. Here we report pretreatment of CHO-IR cells with ... Cited by 32 - Related articles - All 5 versions
- ►nutrition.org ZQ Wang, XH Zhang, JC Russell, M Hulver, … - Journal of Nutrition, 2006 - Am Soc Nutrition Chromium is one of the few trace minerals for which a specific cellular
mechanism of action has not been identified. Recent in vitro studies suggest
that chromium supplementation may improve insulin sensitivity by enhancing ... Cited by 26 - Related articles - BL Direct - All 7 versions
